Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
RLYB
Rallybio Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for RLYB
Full RLYB profile on Quantisnow Follow RLYB and get a push notification the moment its next story breaks.